These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 28836947)
21. A multidisciplinary review of the policy, intellectual property rights, and international trade environment for access and affordability to essential cancer medications. Baxi SM; Beall R; Yang J; Mackey TK Global Health; 2019 Sep; 15(1):57. PubMed ID: 31533850 [TBL] [Abstract][Full Text] [Related]
22. The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries. Mendis S; Fukino K; Cameron A; Laing R; Filipe A; Khatib O; Leowski J; Ewen M Bull World Health Organ; 2007 Apr; 85(4):279-88. PubMed ID: 17546309 [TBL] [Abstract][Full Text] [Related]
23. Price discrimination in essential medicines: evidence from International Drug Price Indicator Guide data. Hanlon M; Zhang R Int Health; 2013 Mar; 5(1):58-63. PubMed ID: 24029847 [TBL] [Abstract][Full Text] [Related]
24. The prices people pay for medicines in Zimbabwe. Gavaza P; Simoyi T; Makunike B; Maponga CC Cent Afr J Med; 2009; 55(1-4):14-9. PubMed ID: 21977842 [TBL] [Abstract][Full Text] [Related]
25. The availability, pricing and affordability of three essential asthma medicines in 52 low- and middle-income countries. Babar ZU; Lessing C; Mace C; Bissell K Pharmacoeconomics; 2013 Nov; 31(11):1063-82. PubMed ID: 24127259 [TBL] [Abstract][Full Text] [Related]
26. Allocating scarce financial resources for HIV treatment: benchmarking prices of antiretroviral medicines in Latin America. Wirtz VJ; Santa-Ana-Tellez Y; Trout CH; Kaplan WA Health Policy Plan; 2012 Dec; 27(8):638-48. PubMed ID: 22367770 [TBL] [Abstract][Full Text] [Related]
27. Availability, prices and affordability of essential medicines in Haiti. Chahal HS; St Fort N; Bero L J Glob Health; 2013 Dec; 3(2):020405. PubMed ID: 24363923 [TBL] [Abstract][Full Text] [Related]
28. Effect of privatization of the drug distribution system on drug prices in Malaysia. Babar ZD; Izham MI Public Health; 2009 Aug; 123(8):523-33. PubMed ID: 19665741 [TBL] [Abstract][Full Text] [Related]
29. Pricing and availability of some essential child specific medicines in Odisha. Swain TR; Rath B; Dehury S; Tarai A; Das P; Samal R; Samal S; Nayak H Indian J Pharmacol; 2015; 47(5):496-501. PubMed ID: 26600637 [TBL] [Abstract][Full Text] [Related]
30. Price, availability and affordability of medicines. Mhlanga BS; Suleman F Afr J Prim Health Care Fam Med; 2014 Jun; 6(1):E1-6. PubMed ID: 26245401 [TBL] [Abstract][Full Text] [Related]
31. The Impact of Price Negotiations on Public Procurement Prices and Access to 8 Innovative Cancer Medicines in a Middle-Income Country: The Case of Mexico. Moye-Holz D; van Dijk JP; Reijneveld SA; Hogerzeil HV Value Health Reg Issues; 2019 Dec; 20():129-135. PubMed ID: 31374426 [TBL] [Abstract][Full Text] [Related]
32. Availability, price and affordability of cardiovascular medicines: a comparison across 36 countries using WHO/HAI data. van Mourik MS; Cameron A; Ewen M; Laing RO BMC Cardiovasc Disord; 2010 Jun; 10():25. PubMed ID: 20534118 [TBL] [Abstract][Full Text] [Related]
33. Cross-sectional pilot study to monitor the availability, dispensed prices, and affordability of opioids around the globe. De Lima L; Pastrana T; Radbruch L; Wenk R J Pain Symptom Manage; 2014 Oct; 48(4):649-59.e1. PubMed ID: 24703944 [TBL] [Abstract][Full Text] [Related]
34. Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study. Chow CK; Ramasundarahettige C; Hu W; AlHabib KF; Avezum A; Cheng X; Chifamba J; Dagenais G; Dans A; Egbujie BA; Gupta R; Iqbal R; Ismail N; Keskinler MV; Khatib R; Kruger L; Kumar R; Lanas F; Lear S; Lopez-Jaramillo P; McKee M; Mohammadifard N; Mohan V; Mony P; Orlandini A; Rosengren A; Vijayakumar K; Wei L; Yeates K; Yusoff K; Yusuf R; Yusufali A; Zatonska K; Zhou Y; Islam S; Corsi D; Rangarajan S; Teo K; Gerstein HC; Yusuf S; Lancet Diabetes Endocrinol; 2018 Oct; 6(10):798-808. PubMed ID: 30170949 [TBL] [Abstract][Full Text] [Related]
35. Approaches to improving access to essential cancer medicines in the WHO South-East Asia Region. Chivukula MV; Tisocki K WHO South East Asia J Public Health; 2018 Sep; 7(2):62-66. PubMed ID: 30136662 [TBL] [Abstract][Full Text] [Related]
36. Affordability of medicines in the European Union. Zaprutko T; Kopciuch D; Kus K; Merks P; Nowicka M; Augustyniak I; Nowakowska E PLoS One; 2017; 12(2):e0172753. PubMed ID: 28241019 [TBL] [Abstract][Full Text] [Related]
37. Short-term differences in drug prices after implementation of the national essential medicines system: A case study in rural Jiangxi Province, China. Wang J; Liu X; Wang S; Chen H; Wang X; Zhou W; Wang L; Zhu Y; Zheng X; Hao M Indian J Pharmacol; 2015; 47(5):535-9. PubMed ID: 26600644 [TBL] [Abstract][Full Text] [Related]
38. Retail prices of essential drugs in Brazil: an international comparison. Nóbrega Ode T; Marques AR; de Araújo AC; Karnikowski MG; Naves Jde O; Silver LD Rev Panam Salud Publica; 2007 Aug; 22(2):118-23. PubMed ID: 17976278 [TBL] [Abstract][Full Text] [Related]
39. Access to Cytotoxic Medicines by Children With Cancer: A Focus on Low and Middle Income Countries. Barr R; Robertson J Pediatr Blood Cancer; 2016 Feb; 63(2):287-91. PubMed ID: 26375626 [TBL] [Abstract][Full Text] [Related]
40. Opioid Medications in Expensive Formulations Are Sold at a Lower Price than Immediate-Release Morphine in Countries throughout the World: Third Phase of Opioid Price Watch Cross-Sectional Study. De Lima L; Arias Casais N; Wenk R; Radbruch L; Pastrana T J Palliat Med; 2018 Oct; 21(10):1458-1465. PubMed ID: 29927698 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]